Literature DB >> 1764042

A novel one-step purification of human alpha-thrombin after direct activation of crude prothrombin enriched from plasma.

P K Ngai1, J Y Chang.   

Abstract

Crude prothrombin enriched from human plasma was directly activated to generate alpha-thrombin without prior exhaustive purification of the proenzyme using a combination of several different types of chromatographic techniques, as in all previously described methodologies. Activated thrombin was separated from other components in a single step by taking advantage of its highly specific affinity to heparin immobilized on a matrix support of Sepharose CL-6B. On the basis of the data presented herein, we have demonstrated the ease with which at least 25 mg of a highly purified enzyme (greater than 97% homogeneous by laser densitometry) can be obtained per litre of plasma. Our product exhibits a specific activity of at least 4000 National Institutes of Health units/mg and is stable after being freeze-dried for the purpose of long-term storage.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1764042      PMCID: PMC1130526          DOI: 10.1042/bj2800805

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  OBSERVATIONS ON THE INTERACTION OF PHOSPHOLIPIDS AND CERTAIN CLOTTING FACTORS IN PROTHROMBIN ACTIVATOR FORMATION.

Authors:  D PAPAHADJOPOULOS; D J HANAHAN
Journal:  Biochim Biophys Acta       Date:  1964-08-19

2.  Liquid chromatographic determination of amino acids after gas-phase hydrolysis and derivatization with (dimethylamino)azobenzenesulfonyl chloride.

Authors:  R Knecht; J Y Chang
Journal:  Anal Chem       Date:  1986-10       Impact factor: 6.986

3.  The synthesis of sulfated dextran beads for isolation of human plasma coagulation factors II, IX, and X.

Authors:  J P Miletich; G J Broze; P W Majerus
Journal:  Anal Biochem       Date:  1980-07-01       Impact factor: 3.365

4.  Preparation and stability of a highly purified human thrombin standard.

Authors:  M Miller-Andersson; P J Gaffney; M J Seghatchian
Journal:  Thromb Res       Date:  1980-10-01       Impact factor: 3.944

Review 5.  Chemistry of the hemostatic mechanism and its relationship to the action of heparin.

Authors:  R D Rosenberg
Journal:  Fed Proc       Date:  1977-01

6.  Manual micro-sequence analysis of polypeptides using dimethylaminoazobenzene isothiocyanate.

Authors:  J Y Chang
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

7.  Characterization of the complementary deoxyribonucleic acid and gene coding for human prothrombin.

Authors:  S J Degen; R T MacGillivray; E W Davie
Journal:  Biochemistry       Date:  1983-04-26       Impact factor: 3.162

8.  High-sensitivity sequencing with a gas-phase sequenator.

Authors:  M W Hunkapiller; R M Hewick; W J Dreyer; L E Hood
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

9.  Coagulant activity of tiger snake (Notechis scutatus scutatus) venom.

Authors:  F Jobin; M P Esnouf
Journal:  Nature       Date:  1966-08-20       Impact factor: 49.962

10.  A simplified procedure for purification of human prothrombin, factor IX and factor X.

Authors:  S P Bajaj; S I Rapaport; C Prodanos
Journal:  Prep Biochem       Date:  1981
View more
  13 in total

1.  Counteracting effect of glycyrrhizin on the hemostatic abnormalities induced by Bothrops jararaca snake venom.

Authors:  Mariane Assafim; Marcos S Ferreira; Flávia S Frattani; Jorge A Guimarães; Robson Q Monteiro; Russolina B Zingali
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

2.  Ixolaris: a factor Xa heparin-binding exosite inhibitor.

Authors:  Robson Q Monteiro; Alireza R Rezaie; José M C Ribeiro; Ivo M B Francischetti
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

3.  Basis for the specificity and activation of the serpin protein Z-dependent proteinase inhibitor (ZPI) as an inhibitor of membrane-associated factor Xa.

Authors:  Xin Huang; Alexey Dementiev; Steven T Olson; Peter G W Gettins
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

4.  Characterization of bothrojaracin interaction with human prothrombin.

Authors:  R Q Monteiro; P E Bock; M L Bianconi; R B Zingali
Journal:  Protein Sci       Date:  2001-09       Impact factor: 6.725

5.  Lonomia obliqua venomous secretion induces human platelet adhesion and aggregation.

Authors:  Markus Berger; José Reck; Renata M S Terra; Walter O Beys da Silva; Lucélia Santi; Antônio F M Pinto; Marilene H Vainstein; Carlos Termignoni; Jorge A Guimarães
Journal:  J Thromb Thrombolysis       Date:  2010-10       Impact factor: 2.300

6.  A thrombin inhibitor from the gut of Boophilus microplus ticks.

Authors:  Clarisse Gravina Ricci; Antônio Frederico Michel Pinto; Markus Berger; Carlos Termignoni
Journal:  Exp Appl Acarol       Date:  2007-08-21       Impact factor: 2.132

7.  Anticoagulant activity of a sulfated galactan: serpin-independent effect and specific interaction with factor Xa.

Authors:  Bianca F Glauser; Ricardo M Rezende; Fabio R Melo; Mariana S Pereira; Ivo M B Francischetti; Robson Q Monteiro; Alireza R Rezaie; Paulo A S Mourão
Journal:  Thromb Haemost       Date:  2009-12       Impact factor: 5.249

8.  Rapid purification of high purity thrombin and preparation of a novel hemostat for clinical purposes.

Authors:  Krishna Kumar Turaga; P Chakradhara Rao; G Sripad
Journal:  Indian J Hematol Blood Transfus       Date:  2008-08-24       Impact factor: 0.900

9.  The allosteric mechanism of activation of antithrombin as an inhibitor of factor IXa and factor Xa: heparin-independent full activation through mutations adjacent to helix D.

Authors:  Alexey Dementiev; Richard Swanson; Ryan Roth; Giulia Isetti; Gonzalo Izaguirre; Steven T Olson; Peter G W Gettins
Journal:  J Biol Chem       Date:  2013-09-25       Impact factor: 5.157

10.  Autoactivation of thrombin precursors.

Authors:  Nicola Pozzi; Zhiwei Chen; Fatima Zapata; Weiling Niu; Sergio Barranco-Medina; Leslie A Pelc; Enrico Di Cera
Journal:  J Biol Chem       Date:  2013-03-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.